Patent details

EP1959939 Title: USE OF A3 ADENOSINE RECEPTOR AGONIST IN OSTEOARTHRITIS TREATMENT

Basic Information

Publication number:
EP1959939
PCT Application Number:
PCT/IL/2006/001374
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP068215946
PCT Publication Number:
WO/2007/063538
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF A3 ADENOSINE RECEPTOR AGONIST IN OSTEOARTHRITIS TREATMENT
French Title of Invention:
UTILISATION DE L'AGONISTE DES RECEPTEURS DE L'ADENOSINE A3 DANS LE TRAITEMENT DE L'OSTEOARTHRITE
German Title of Invention:
VERWENDUNG VON A3-ADENOSIN-REZEPTOR-AGONISTEN BEI DER BEHANDLUNG VON OSTEOARTHRITIS
SPC Number:

Dates

Filing date:
29/11/2006
Grant date:
11/01/2012
EP Publication Date:
11/01/2012
PCT Publication Date:
07/06/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/08/2008
EP B1 Publication Date:
11/01/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/11/2012
Expiration date:
29/11/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/11/2006
 
 

Name:
Can-Fite Biopharma Ltd.
Address:
10 Bareket Street P.O. Box 7537, Petach Tikva 49170, Israel (IL)

Inventor

Name:
FISHMAN Pnina
Address:
Israel (IL)

Priority

Priority Number:
740631 P
Priority Date:
30/11/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/00;
Filing date Document type Number of pages